79352355 - VECTAB

Information

• Trademark
• 79352355

• Source

• Serial Number

  79352355

• Registration Number

  7349426

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  August 01, 2022
  2 years ago

• Registration Date

  April 09, 2024
  10 months ago

• Transaction Date

  January 17, 2025
  21 days ago

• Status Date

  April 09, 2024
  10 months ago

• Published for Opposition Date

  January 23, 2024
  a year ago

• Location Date

  December 20, 2023
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  STEEL, ALYSSA

• Attorney Docket Number

  19250-0465

  Attorney Name

  Douglas T. Johnson

  Law Office Assigned Location Code

  N60

• Owners

  • VectorY B.V.

Case File Statements

• GS0051: Viral systems comprised of viral vectors combined with antibodies; gene therapy systems comprised of viral vectors combined with antibodies; nucleic acid delivery systems being therapeutic agents for delivery to human tissue namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for the treatment neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; clinical medical reagents for use in nucleic acid-based therapy, cell therapy, pharmaceutical preparations, prophylaxis products preparations and other pharmaceutical products preparations and other pharmaceutical products preparations for use in nucleic acid-based therapy, gene therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases
• GS0441: Medical treatment by gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
• GS0421: Scientific and medical research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Scientific and medical research and product development in the field of pharmaceutics

Case File Event Statements

• 5/19/2023 - a year ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/13/2022 - 2 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 10/14/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/18/2022 - 2 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/11/2023 - a year ago

  4 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 5/18/2023 - a year ago

  5 - ASSIGNED TO EXAMINER Type: DOCK

• 5/20/2023 - a year ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/27/2023 - a year ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/27/2023 - a year ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 7/22/2023 - a year ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 12/7/2023 - a year ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/7/2023 - a year ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/8/2023 - a year ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/12/2023 - a year ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/12/2023 - a year ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/12/2023 - a year ago

  16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/12/2023 - a year ago

  17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/18/2023 - a year ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/3/2024 - a year ago

  21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/3/2024 - a year ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/3/2024 - a year ago

  20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/22/2024 - a year ago

  22 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 1/23/2024 - a year ago

  23 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/23/2024 - a year ago

  24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/13/2024 - 11 months ago

  26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 4/9/2024 - 10 months ago

  29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 4/9/2024 - 10 months ago

  28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 3/13/2024 - 11 months ago

  25 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 4/1/2024 - 10 months ago

  27 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 10/19/2024 - 3 months ago

  30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 1/1/2025 - a month ago

  32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 1/17/2025 - 21 days ago

  33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 1/1/2025 - a month ago

  31 - FINAL DISPOSITION PROCESSED Type: FIMP